Lin Elizabeth Yeu (CIK 1842190) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-19). Recent activity: Sell TARS (375 shares), Sell TARS (379 shares), Sell TARS (390 shares), Buy TARS (2,511 shares), Buy TARS (6,819 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-19 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | Sell | 375 | $26,032 |
| 2026-03-19 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | Sell | 379 | $26,041 |
| 2026-03-19 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | Sell | 390 | $26,130 |
| 2026-03-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | Buy | 2,511 | $0 |
| 2025-12-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | Buy | 6,819 | $0 |
| 2025-12-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | Sell | 2,078 | $165,201 |
| 2025-06-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | Buy | 3,350 | $0 |
| 2025-06-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | Sell | 1,006 | $41,326 |
Source: SEC Form 4 filings · as of 2026-03-19